person · Reporting owner

Robison William J

Disclosed activity across 1 company

Tapewire entity: 175707
SEC CIK: 0001372151

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
NEOGENOMICS INCNEO · Entity 2096	Director	May 25, 2017	May 31, 2017

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

NEOGENOMICS INC

Report date May 25, 2017 · Filed May 31, 2017

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	183,348	Reported balance After 2017-05-30 transaction · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · 2017-05-30 · Exercise / conversion · Acquired 7,222 · Balance 183,348
Common StockSEC Table I · non-derivative	Direct	176,126	Reported balance Holding disclosure · report date 2017-05-25 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 176,126
Restricted StockSEC Table II · derivative / convertible security · Expires 2017-03-31	Direct	0	Reported balance After 2017-05-30 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2017-05-30 · Conversion · Disposed 2,150 · Balance 0 F1: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. F2: Restricted stock has vested and restricted stock certificate issued for shares of the company's common stock. F3: 537.5 shares will vest on June 30, 2016 and thereafter, 537.5 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2017.
Restricted StockSEC Table II · derivative / convertible security · Expires 2017-03-31	Direct	0	Reported balance After 2017-05-30 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2017-05-30 · Conversion · Disposed 5,072 · Balance 0 F1: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. F2: Restricted stock has vested and restricted stock certificate issued for shares of the company's common stock. F4: 1,690.6 shares will vest on September 30, 2016 and thereafter, 1,690.7 shares will vest on the last day of each calendar quarter for the next two fiscal quarters up to March 31, 2017.
Restricted StockSEC Table II · derivative / convertible security	Direct	8,667	Reported balance After 2017-05-25 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2017-05-25 · Grant · Acquired 8,667 · Balance 8,667 F1: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. F8: The restricted stock will vest as follows; 2,166 units at June 30, 2017 and thereafter, 2,167 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2018. F9: These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date.
StockOption (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.27 · Expires 2022-05-25	Direct	10,000	Reported balance After 2017-05-25 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2017-05-25 · Grant · Acquired 10,000 · Balance 10,000 F7: On May 25, 2017, Mr. Robison was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.78 · Expires 2020-05-06	Direct	6,667	Reported balance Holding disclosure · report date 2017-05-25 · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · Balance 6,667 F5: On May 6, 2015 Mr. Robison was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.11 · Expires 2021-07-28	Direct	8,333	Reported balance Holding disclosure · report date 2017-05-25 · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · Balance 8,333 F6: On July 28, 2016, Mr. Robison was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.

F2: Restricted stock has vested and restricted stock certificate issued for shares of the company's common stock.

F3: 537.5 shares will vest on June 30, 2016 and thereafter, 537.5 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2017.

F4: 1,690.6 shares will vest on September 30, 2016 and thereafter, 1,690.7 shares will vest on the last day of each calendar quarter for the next two fiscal quarters up to March 31, 2017.

F5: On May 6, 2015 Mr. Robison was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F6: On July 28, 2016, Mr. Robison was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F7: On May 25, 2017, Mr. Robison was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.

F8: The restricted stock will vest as follows; 2,166 units at June 30, 2017 and thereafter, 2,167 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2018.

F9: These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 30, 2017 Filed May 31, 2017 01:25 UTC	NEOGENOMICS INC NEO · Entity 2096	ConversionRestricted Stock · Derivative	5,072	$0.00	$0.00	Disclosure SEC source: 0001209191-17-036317 · doc4.xml · derivative · entry 4 Robison William J · CIK 0001372151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,072 shares Expires 2017-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. F2 · kind: Restricted stock has vested and restricted stock certificate issued for shares of the company's common stock. F4 · derivative.exercise_date: 1,690.6 shares will vest on September 30, 2016 and thereafter, 1,690.7 shares will vest on the last day of each calendar quarter for the next two fiscal quarters up to March 31, 2017. Read SEC document
May 30, 2017 Filed May 31, 2017 01:25 UTC	NEOGENOMICS INC NEO · Entity 2096	ConversionRestricted Stock · Derivative	2,150	$0.00	$0.00	Disclosure SEC source: 0001209191-17-036317 · doc4.xml · derivative · entry 3 Robison William J · CIK 0001372151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,150 shares Expires 2017-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. F2 · kind: Restricted stock has vested and restricted stock certificate issued for shares of the company's common stock. F3 · derivative.exercise_date: 537.5 shares will vest on June 30, 2016 and thereafter, 537.5 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2017. Read SEC document
May 30, 2017 Filed May 31, 2017 01:25 UTC	NEOGENOMICS INC NEO · Entity 2096	Exercise / conversionCommon Stock	7,222	$0.00	$0.00	Disclosure SEC source: 0001209191-17-036317 · doc4.xml · nonDerivative · entry 2 Robison William J · CIK 0001372151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 25, 2017 Filed May 31, 2017 01:25 UTC	NEOGENOMICS INC NEO · Entity 2096	GrantRestricted Stock · Derivative	8,667	$0.00	$0.00	Disclosure SEC source: 0001209191-17-036317 · doc4.xml · derivative · entry 8 Robison William J · CIK 0001372151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,667 Underlying: Common Stock · 8,667 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. F8 · derivative.exercise_date: The restricted stock will vest as follows; 2,166 units at June 30, 2017 and thereafter, 2,167 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2018. F9 · derivative.expiration_date: These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date. Read SEC document
May 25, 2017 Filed May 31, 2017 01:25 UTC	NEOGENOMICS INC NEO · Entity 2096	GrantStockOption (Right to Buy) · Derivative	10,000	$7.27 Strike: $7.27	$72,700.00	Disclosure SEC source: 0001209191-17-036317 · doc4.xml · derivative · entry 7 Robison William J · CIK 0001372151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Comon Stock · 10,000 shares Expires 2022-05-25 F7 · derivative.exercise_date: On May 25, 2017, Mr. Robison was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.